Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.14
+0.51 (3.07%)
At close: Aug 14, 2026, 4:00 PM EDT
17.14
0.00 (0.00%)
After-hours: Aug 14, 2026, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $733.61 million as of August 14, 2026. Its market cap has increased by 169.97% in one year.
Market Cap
733.61M
Enterprise Value
563.45M
1-Year Change
169.97%
Ranking
Category
Stock Price
$17.14
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $733.61M, an increase of 137.58%. That is a compound annual growth rate of 110.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 733.61M | 216.40% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 771.19M |
| Achieve Life Sciences | 753.25M |
| Phathom Pharmaceuticals | 744.26M |
| Shattuck Labs | 741.18M |
| CytomX Therapeutics | 732.14M |
| Monopar Therapeutics | 730.96M |
| BridgeBio Oncology Therapeutics | 729.78M |
| Cybin | 721.49M |